Lidocaine 5% Topical Anorectal Cream
NDC Package 73715-002-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lidocaine 5% Topical Anorectal Cream is when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Marketed by Mohnark Pharmaceuticals Inc., this product is identified by NDC 73715-002 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
73715-002-01
Package Description
30 g in 1 TUBE
Product Code
11-Digit Billing Format
73715000201

Clinical Specifications

Proprietary Name
Lidocaine 5% Topical Anorectal Cream
Dosage Form
-
Usage Information
When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or soft cloth before applying.Adults and children 12 years and older: apply externally to the affected area up to 6 times a day.Children under 12 years of age: consult a doctor.

Regulatory & Marketing

Labeler Name
Mohnark Pharmaceuticals Inc.
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-15-2020
Listing Expiration
12-31-2026
Exclude Flag
I
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73715-002-01 identifies a specific commercial package of 30 g in 1 tube of Lidocaine 5% Topical Anorectal Cream, labeled by Mohnark Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mohnark Pharmaceuticals Inc. on June 15, 2020. The current certification is valid through December 31, 2026.

How is this Mohnark Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73715000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73715-002-01
11-Digit CMS (5-4-2)
73715-0002-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.